Cancer Tumor Profiling Market By Technique Type (Genomics, Epigenetics, Metabolomics, Proteomics), By Technology (Immunoassays, In Situ Hybridization, PCR), By Application (Research And Clinical Application), Forecasts to 2027

9890
Present Value (M$)
2019
20690
Forecast Value (M$)
2027
9.6%
CAGR (%)

Cancer Tumor Profiling Market is forecasted to grow at a rate of 9.6% from USD 9.89 Billion in 2019 to USD 20.69 Billion in 2027.

Main companies

  • Caris Life Sciences
  • Foundation Medicine
  • GenomeDX
  • Genomic Health
  • Guardant Health
  • Helomics Corporation
  • HTG Molecular Diagnostics
  • Inc.
  • Nanostring Technologies
  • Neogenomics Inc.
  • Oxford Gene Technology
  • Qiagen N.V.
  • Ribomed Biotechnologies Inc.